(redirected from Alpha adrenergic)
Also found in: Dictionary, Medical, Encyclopedia.
Related to Alpha adrenergic: Beta adrenergic
Graphic Thesaurus  🔍
Display ON
Animation ON
  • all
  • noun
  • adj

Synonyms for adrenergic

drug that has the effects of epinephrine

relating to epinephrine (its release or action)

References in periodicals archive ?
The uroflowmetric parametres in patients taking alpha adrenergic blockers have never been evaluated.
In March 2000, Synaptic began making non-exclusive licenses available to companies in need of Synaptic's portfolio of intellectual property on the alpha adrenergic receptors for drug discovery.
1,2) Alpha adrenergic receptor like [alpha]1A and [alpha]1D have been documented to be distributed the in the lower urinary tract and the distal ureter and the use of alpha adrenergic receptor blockers like Tamsulosin have shown considerable promise in treating the stent related symptoms.
Phenylephrine is a sympathomimetic agent which acts primarily as an alpha adrenergic agonist.
In March of this year Synaptic began to make available non-exclusive licenses to its alpha adrenergic and benign prostatic hypertrophy patents.
6,7) The expectant approach by using alpha adrenergic receptor antagonist for management of distal ureteric stones used as adjuvant medical expulsive therapy (MET), and be able to reduce symptoms and facilitate stone expulsion due to the presence of alpha and beta adrenergic receptors (AR) in the human ureter.
Synaptic Pharmaceutical Corporation (Paramus, NJ; 201-261-1331) announced that it has been awarded United States Patent 6,083,705 for the use of the alpha adrenergic 1D receptor to screen compounds that bind to it.
5%, an alpha adrenergic receptor agonist with a beta adrenergic receptor inhibitor, for the reduction of elevated intraocular pressure (IOP) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled IOP.
Exclusion criteria included the patients on alpha adrenergic receptor blockers, local sepsis at the site of proposed puncture, patient with known hypersensitivity to study drug, patients being treated with anticoagulants, CNS active drugs, patients suffering from bleeding diathesis or coagulation disorders, spinal deformity or tuberculosis spine, increased intracranial pressure, patients with some psychiatric history, patients with neurological disease with motor and sensory deficit.